1. Home
  2. FATE vs MYPS Comparison

FATE vs MYPS Comparison

Compare FATE & MYPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fate Therapeutics Inc.

FATE

Fate Therapeutics Inc.

HOLD

Current Price

$1.34

Market Cap

139.6M

Sector

Health Care

ML Signal

HOLD

Logo PLAYSTUDIOS Inc.

MYPS

PLAYSTUDIOS Inc.

HOLD

Current Price

$0.50

Market Cap

64.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
FATE
MYPS
Founded
2007
2011
Country
United States
United States
Employees
N/A
568
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
139.6M
64.2M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
FATE
MYPS
Price
$1.34
$0.50
Analyst Decision
Buy
Buy
Analyst Count
6
3
Target Price
$4.10
$2.00
AVG Volume (30 Days)
1.5M
316.1K
Earning Date
05-29-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
29.88
N/A
EPS
N/A
N/A
Revenue
$6,646,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.05
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.66
$0.43
52 Week High
$1.94
$1.68

Technical Indicators

Market Signals
Indicator
FATE
MYPS
Relative Strength Index (RSI) 49.31 44.45
Support Level $0.96 $0.43
Resistance Level $1.35 $0.53
Average True Range (ATR) 0.13 0.03
MACD -0.02 0.01
Stochastic Oscillator 20.43 63.31

Price Performance

Historical Comparison
FATE
MYPS

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About MYPS PLAYSTUDIOS Inc.

PLAYSTUDIOS Inc is engaged in gaming and related business. The Company develops and operates online and mobile social gaming applications (games or game), many of which incorporate a loyalty program offering real world rewards provided by a collection of awards partners. The Company's games are free-to-play and available via the Apple App Store, Google Play Store, Amazon Appstore and Facebook (collectively, platforms or platform operators). The Company creates games based on its own original content as well as third-party licensed brands. The Company generates revenue through the in-game sales of virtual currency and through advertising. The company has one operating segment with one business activity, developing and monetizing social games.

Share on Social Networks: